India Pediatric Drugs and Vaccines Market Outlook to 2021 - Rise in Prevalence of Chronic Diseases and Inclusion of Several New Vaccines in National Immunization Programme to Shape Future Growth
January 2017
138
About the Report
About the Report
The report titled "India Pediatric Drugs and Vaccines Market Outlook to 2021 - Rise in Prevalence of Chronic Diseases and Inclusion of Several New Vaccines in National Immunization Programme to Shape Future Growth" provides a comprehensive analysis of the pediatric drugs and vaccines market in India and covers market size and segmentation of overall market by drugs and vaccines. The report covers the further segmentations of different spaces such as Drugs and Vaccines into sub segments based on their individual characteristics. The sub segments of Drugs (Patented and Generic, Treatment and Management, Drug Classes, Prescription and OTC, Online and Offline) are then considered separately and analysis on them has been done individually. Similarly, the sub segments of Vaccines (Monovalent and Multivalent, Technology, Indication) have also been considered. The report covers detailed profiles of leading players in the different sub segments in the market. The potential and future outlook has been individually discused for India Pediatric Drug and Vaccine market. The report provides detailed analysis of segments, trends & developments, growth drivers and major restraints and challenges within the industry. The report also serves as a benchmark for existing players and for new players who wish to capitalize on the market potential and investors who are looking forward to venture into pediatric drugs and vaccines market in India.
India Pediatric Drugs Market
India is a home of the largest pediatric population of the world and also has the highest number of annual child births in the world. However, almost ~% of the medicines used in children presently has never been studied for their efficacy in pediatric population. The pediatric drugs market in India grew at a staggering CAGR of ~% during the period FY'2011-FY'2016 exhibiting the annual revenue of INR ~ billion in FY'2011 which inclined to INR ~ billion in FY'2016. Owing to an astounding number of births in the country, the pediatric drugs market has showcased growth at a faster pace than the overall pharmaceutical market of the country during the concerned period.
Segmentation
By Product Type (Patented and Generic): The market for pediatric drugs and vaccines in India is entirely driven by companies manufacturing generic drug formulations. Almost all pharmaceutical companies operating in the country have expertise in developing generic drugs so as to cater to the underprivileged population at a much cheaper price. Generic drug therefore comprised almost ~% of the market share as of FY'2016 whereas patented drugs accounted for ~% market share.
By Usage (Treatment and Management): A large part of drugs sold in the country is meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drugs are most commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Owing to less prevalence of lifestyle diseases amongst pediatric population, market share of drugs meant for management of diseases has been low. Drugs meant for management of diseases accounted for ~% market share as compared to ~% for treatment of diseases.
By Drug Classes (Anti-Infectives, Antihistamines, Cardiovascular Drugs and Others): Anti-infectives were the most frequently prescribed drug class by pediatricians, with over ~% of the prescriptions had some form of prescribed antibiotics. This was due to wide scale prevalence of respiratory diseases among children. Anti-infectives accounted for a market share of ~% as of FY'2016 as compared to anti-histamines (~%), cardiovascular drugs (~%) and all other (~%) categories of drugs.
By Procurement Method (Prescription and OTC): In India, parents always consult a doctor for their children's illness and therefore only buy drugs that are prescribed by a healthcare professional. Scenario is same in both rural and urban areas as parents are very conscious about children's well being and are not willing to rely on OTC drugs without proper knowledge and supervision. Prescription drugs therefore contributed to around ~% in market share as compared to ~% by OTC drug as of FY'2016.
By Distribution Channel (Online and Offline): Currently, procurement of pediatric drugs is almost entirely done through offline medium from hospital pharmacies, retail pharmacies, doctors or institutional health centers. Since the requirement of drugs is usually on an urgent basis, parents don't prefer placing an order online and receive it a later date. As a result, offline sales of drugs accounted for almost ~% of the drug sales as compared to ~% by online medium.
India Pediatric Vaccines Market
India has emerged as the leading vaccine producer in the world, in terms of doses of vaccines produced. The country has ~ major vaccine manufacturing facilities across the country as of FY'2016. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). More than ~% of all measles vaccines used globally are produced in India.
The Indian pediatric market for vaccines has grown at a remarkable CAGR of ~% during the period FY'2011-FY'2016. The growth was attributed to some crucial vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian companies constantly featured in WHO's prequalified list coupled with the fact that Indian companies (Serum Institute of India, Bharat Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO, UNICEF, PATH and other UN agencies. The market for pediatric vaccines grew from INR ~ billion in FY'2011 to INR ~ billion in FY'2016.
Segmentation
By Type of Vaccine A large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form. Monovalent vaccines therefore comprised for a market share of ~% as compared to ~% by multivalent forms.
By Technology: Inactivated vaccines were the earliest forms of vaccines developed by scientists and continue to be widely used in the country. Killed or inactivated vaccine comprised a market share of ~% as compared to ~% by live or attenuated, ~% by toxoid vaccines, ~% by subunit forms, ~% by conjugate vaccines and remaining ~% by all other forms.
By Indication: Hepatitis B vaccines accounted for a market share of ~% as compared to ~% by polio, ~% by HiB, ~% by MMR, ~% by DTP, ~% by BCG and ~% by all other indications as of FY'2016.
Key Topics Covered in the Report:
- Value Chain Analysis of India Pediatric Drugs and Vaccine Market
- India Pediatric Drugs and Vaccine Market by Value, FY'2011-FY'2016
- India Pediatric Drugs Market Introduction and Size, FY'2011-FY'2016
- India Pediatric Drugs Market Segmentation by Product Type (Patented and Generic), by Usage (Treatment and Management), by Drug Classes (Anti-infectives, Antihistamines, Cardiovascular drugs and Others), by Procurement Method (Prescription and OTC), by Distribution Channel (Offline and Online), FY'2016
- Competitive Landscape of Major Players in India Pediatric Drugs Market
- India Pediatric Drugs Future Market Outlook, FY'2017-FY'2021
- India Pediatric Vaccines Market introduction and Size, FY'2011-FY'2016
- India Pediatric Vaccines Market Segmentation by Vaccine Type (Monovalent and Multivalent), by Technology (Live or attenuated, Killed or inactivated, Toxoid, Conjugate, Subunit and Others), by Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others), FY'2016
- Competitive Landscape of Major Players in India Pediatric Vaccines Market
- Pipeline Analysis of Global and India Pediatric Vaccine Market
- India Pediatric Vaccines Future Market Outlook, FY'2017-FY'2021
- Porter Five Forces Analysis in India Pediatric Drugs and Vaccines Market
- Issues and Challenges in India Pediatric Drugs and Vaccines Market
- Government Regulations in India Pediatric Drugs and Vaccines Market
- Analyst Recommendations
- Macro Economic Factors impacting India Pediatric Drugs and Vaccines Market, 2011-2021
Products
Products
Anti-infectives, Antihistamines, Cardiovascular Drugs, Live or Attenuated vaccines, Killed or Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, Subunit Vaccines and Recombinant Vaccines
Companies
Sun Pharmaceuticals, Lupin Pharmaceuticals, Cipla, Dr. Reddy's Laboratories, Abbott India, Serum Institute of India, Panacea Biotec, Bharat Biotech, GSK Pharmaceuticals, Biological E Limited
Table of Contents
Table of Contents
1. Executive Summary
India Pediatric Drugs Market
Segmentation
Future Outlook
India Pediatric Vaccines Market
Segmentation
Future Outlook
1.1. Market Definitions
1.2. Abbreviations
1.3. Research Methodology
Variables (Dependent & Independent)
Multi Factor Based Sensitivity Model
Regression Matrix
Limitations
Final Conclusion
2. Value Chain Analysis of India Pediatric Drugs and Vaccines Market
Manufacturing and Distribution
Retailing
Infrastructure Challenges
Areas to be Focused on
Comparison of Logistics Cost Across India, China and EU
3. India Pediatric Drugs and Vaccines Market, FY'2011-FY'2016
4. India Pediatric Drugs Market Introduction and Size, FY'2011-FY'2016
5. India Pediatric Drugs Market Segmentation
5.1. By Product Type (Patented and Generic), FY'2016
5.2. By Usage (Treatment and Management), FY'2016
5.3. By Drug Classes (Anti-Infectives, Antihistamines, Cardiovascular Drugs and Others), FY'2016
5.4. By Procurement Method (Prescription and OTC), FY'2016
5.5. By Distribution Channel (Offline and Online), FY'2016
6. Competitive Landscape of Major Players in India Pediatric Drugs Market
6.1. Lupin Pharmaceuticals
Product Portfolio
6.2. Cipla
Product Portfolio
6.3. Sun Pharmaceuticals
Product Portfolio
6.4. Dr. Reddy's Laboratories
Product Portfolio
6.5. Abbott India Limited
Product Portfolio
7. India Pediatric Drugs Market Future Outlook, FY'2017-FY'2021
8. India Pediatric Vaccines Market Introduction and Size, FY'2011-FY'2016
Current Scenario of Immunization in India
9. India Pediatric Vaccines Market Segmentation
9.1. By Type of Vaccine (Monovalent and Multivalent), FY'2016
9.2. By Technology (Live or Attenuated, Inactivated or Killed, Toxoid, Conjugate, Subunit and Others), FY'2016
9.3. By Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others), FY'2016
10. Competitive Landscape of Major Players in India Pediatrics Vaccine Market
10.1. Serum Institute of India
Product Portfolio
Pipeline Products
10.2. Panacea Biotec
Product Portfolio
Pipeline Products
10.3. Bharat Biotech
Product Portfolio
Pipeline Products
10.4. GSK Pharmaceuticals Ltd
Product Portfolio
Pipeline Products
10.5. Biological E Limited
Product Portfolio
Pipeline Products
11. Pipeline Analysis of Global and India Pediatric Vaccines market
11.1. Phase 3 Vaccines Anticipated Launch in India
11.2. Vaccines Under Development Globally
12. India Pediatric Vaccines Market Future Outlook, FY'2017-FY'2021
Universal Immunization Programme of Government of India
IPV
Rotavirus Vaccines
Pneumonia Vaccines
Dengue Vaccine
Government Encouragement
13. Government Regulations in India Pediatric Drugs and Vaccines Market
India's Emergence as a Global Destination for Clinical Trials
14. Porter Five Forces Analysis in India Pediatric Drugs and Vaccines Market
15. Issues and Challenges in India Pediatric Drugs and Vaccines Market
16. Analyst Recommendations
17. Macroeconomic Factors in India Pediatric Drugs and Vaccines Market
17.1. Number of Pediatricians in India, 2011-2021
17.2. Under Five Mortality Per 1,000 Live Births, 2011-2021
17.3. Pediatric Population of India, 2011-2021
17.4. Number of Births in India, 2011-2021
17.5. Pharmaceutical Sales as a Proportion of Healthcare Expenditure, 2011-2021
Disclaimer
Contact Us
List of Figure
Figure 2-1: Value Chain of India Pediatric Drugs and Vaccines Market
Figure 3-1: India Pediatric Drugs and Vaccine Market Size on the Basis of Revenues in INR Billion, FY'2011-FY'2016
Figure 4-1: India Pediatric Drugs Market Size on the Basis of Revenues in INR Billion, FY'2011-FY'2016
Figure 5-1: India Pediatrics Drug Market Segmentation on the basis of Product Type (Patented or Generic) by Revenues in Percentage (%), FY'2016
Figure 5-2: India Pediatric Drugs Market Segmentation on the Basis of Usage (Treatment and Management) by Revenues in Percentage (%), FY'2016
Figure 5-3: Leading Causes of Death in Children under 5 Years of Age in India on the Basis of Percentage (%), 2015
Figure 5-4: India Pediatric Drugs Market Segmentation on the Basis of Drug Classes (Anti-infectives, Anti-histamines, Cardiovascular Drugs and Others) by Revenues in Percentage (%), FY'2016
Figure 5-5: Market Share of Leading Prescribed Antibiotics by Revenues in India Anti-Infectives Market in Percentage (%), FY'2016
Figure 5-6: India Pediatrics Drug Market Segmentation on the Basis of Procurement (Prescription and OTC) by Revenues in Percentage (%), FY'2016
Figure 5-7: India Pediatrics Drug Market Segmentation on the Basis of Distribution Channel (Offline and Online) by Revenues in Percentage (%), FY'2016
Figure 6-1: Lupin Pharmaceuticals Historical Timeline
Figure 6-2: Lupin Pharmaceuticals Domestic and Export Revenues, EBITDA and R&D Expenditure in INR Billion, FY'2012-FY'2016
Figure 6-3: Lupin Market Revenue by Formulation on the Basis of Revenue in terms of Percentage (%), FY'2016
Figure 6-4: Lupin Pharmaceuticals Geographical Breakdown of Revenues in Percentage (%), FY'2016
Figure 6-5: Cipla Domestic and Export Revenues and Profit for the Year in INR Billion, FY'2011-FY'2016
Figure 6-6: Sun Pharmaceuticals Domestic and Export Revenues, EBITDA and R&D Expenditure in INR Billion, FY'2012-FY'2016
Figure 6-7: Dr. Reddy's Laboratories Domestic and Export Revenues, Gross Profit and R&D Expenditure in INR Billion, FY'2012-FY'2016
Figure 6-8: Dr. Reddy's Laboratories Geographical Breakdown of Revenues in Percentage (%), FY'2016
Figure 6-9: Abbott India Domestic and Export Revenues and Gross Profit in INR Billion, FY'2012-FY'2016
Figure 7-1: India Pediatric Drugs Market Future Outlook on the Basis of Revenues in INR Billion, FY'2017-FY'2021
Figure 8-1: India Pediatric Vaccines Market Size on the Basis of Revenues in INR Billion, FY'2011-FY'2016
Figure 9-1: India Pediatric Vaccines Market on the Basis of Type of Vaccine (Monovalent and Multivalent) by Revenues in Percentage (%), FY'2016
Figure 9-2: India Pediatrics Vaccine Market on the Basis of Technology (Live or Attenuated, Inactivated or Killed, Toxoid, Conjugate, Subunit and Others) by Revenues in Percentage (%), FY'2016
Figure 9-3: India Pediatric Vaccines Market on the Basis of Indication Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others) by Revenues in Percentage (%), FY'2016
Figure 10-1: Serum Institute of India Historical Developments
Figure 10-2: Panacea Biotec Historical Developments
Figure 10-3: Panacea Biotec Revenues from Pediatric Vaccines Segment in INR Billion, FY'2011-FY'2016
Figure 10-4: Bharat Biotech Historical Developments
Figure 10-5: Bharat Biotech Revenues from Pediatric Vaccines Segment in INR Billion, FY'2012-FY'2015
Figure 10-6: GSK Pharmaceuticals Historical Developments
Figure 10-7: GSK Pharmaceuticals Revenues from Pediatric Vaccines in INR Billion, FY'2011-FY'2016
Figure 10-8: Biological E Limited Historical Developments
Figure 11-1: Pipeline Analysis of Global Pediatric Vaccines Market on the Basis of Vaccines under Clinical Trials by Phase of Development in Percentage (%), December 2016
Figure 12-1: India Pediatrics Vaccine Market Future Outlook on the Basis of Revenues in INR Billion, FY'2017-FY'2021
Figure 13-1: Clinical Trial Approval Flowchart
Figure 13-2: Vaccine Approval and Development Path in India
Figure 14-1: Porter's Five Force Analysis of India Pediatric Drugs and Vaccines Market
Figure 17-1: Number of Pediatricians in India, 2011-2021E
Figure 17-2: Under Five Mortality per 1,000 Live Births, 2011 – 2021E
Figure 17-3: Pediatric (0-18 years) Population of India in Millions, 2011-2021E
Figure 17-4: Number of Births in India in Millions, 2011-2021E
Figure 17-5: Pharmaceutical Sales as a Proportion of Healthcare Expenditure in Percentage (%), 2011-2021E
List of Table
Table 1-1: Correlation Matrix of India Pediatrics Drug and Vaccine Market
Table 1-2: Regression Matrix of India Pediatric Drugs and Vaccines Market
Table 2-1: Developments in Major Hubs of India Pediatric Drugs and Vaccines Market to Increase the Efficiency of Logistics Network
Table 2-2: Comparison of Logistics Cost Across India, China and EU
Table 4-1: Major Growth Drivers in India Pediatrics Drugs Market
Table 4-2: Mergers, Acquisitions and Strategic Tie-Ups in India Pediatric Drugs Market
Table 5-1: India Pediatric Drugs Market Segmentation on the Basis of Product Type (Patented or Generic) by Revenues in INR Billion, FY'2016
Table 5-2: India Pediatric Drugs Market Segmentation on the Basis of Usage (Treatment and Management) by Revenues in INR Billion, FY'2016
Table 5-3: Leading Causes of Death in Children under 5 Years of Age in India, 2015
Table 5-4: India Pediatric Drugs Market Segmentation on the Basis of Drug Classes (Anti-Infectives, Anti-histamines, Cardiovascular Drugs and Others) by Revenues in INR Billion, FY'2016
Table 5-5: India Pediatric Drugs Market Segmentation on the Basis of Procurement (Prescription and OTC) by Revenues in INR Billion, FY'2016
Table 5-6: India Pediatric Drugs Market Segmentation on the Basis of Distribution Channel (Offline and Online) by Revenues in INR Billion, FY'2016
Table 5-7: Snapshot of Online Pharmacies in India, FY'2016
Table 6-1: Lupin Pharmaceuticals Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Recent Developments and some other KPI's)
Table 6-2: Lupin Pharmaceuticals Product Portfolio of Leading Pediatric Drugs
Table 6-3: Cipla Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Recent Developments and some other KPI's)
Table 6-4: Cipla Product Portfolio of Leading Pediatric Drugs
Table 6-5: Sun Pharmaceuticals Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Recent Developments and some other KPI's)
Table 6-6: Sun Pharmaceuticals Product Portfolio of Leading Pediatric Drugs
Table 6-7: Dr. Reddy's Laboratories Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Recent Developments and some other KPI's)
Table 6-8: Dr. Reddys's Laboratories Product Portfolio of Leading Pediatric Drugs
Table 6-9: Abbott Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Recent Developments and some other KPI's)
Table 6-10: Abbott India Product Portfolio of Leading Pediatric Drugs
Table 7-1: Future Drivers for India Pediatric Drugs Market
Table 8-1: India Pediatric Vaccines Market Growth Drivers
Table 8-2: Vaccine R&D Institutions in India
Table 8-3: Vaccine Technology Transfer from Institutions to Industry
Table 8-4: WHO Recommended Immunization Schedule for all Children
Table 8-5: WHO Recommended Immunization Schedule for Children in Some High-Risk Populations
Table 8-6: WHO Recommended Immunization Schedule for Children Receiving Vaccinations from Immunization Programmes with Certain Characteristics
Table 8-7: WHO Recommended Immunization Schedule for Children Residing in Certain Regions
Table 8-8: National Immunization Schedule of India for all Children
Table 9-1: India Pediatric Vaccines Market on the Basis of Type of Vaccine (Monovalent and Multivalent) by Revenues in INR Billion, FY'2016
Table 9-2: India Pediatrics Vaccine Market on the Basis of Technology (Live or Attenuated, Inactivated or Killed, Toxoid, Conjugate, Subunit and Others) by Revenues in INR Billion, FY'2016
Table 9-3: India Pediatric Vaccines Market on the Basis of Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG And Others) by Revenues in INR Billion, FY'2016
Table 10-1: Serum Institute of India Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Strategies and some other KPI's)
Table 10-2: Serum Institute of India Product Portfolio
Table 10-3: Serum Institute of India Pipeline Products
Table 10-4: Panacea Biotec Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Strategies and some other KPI's)
Table 10-5: Panacea Biotec Product Portfolio
Table 10-6: Panacea Biotec Pipeline Products
Table 10-7: Bharat Biotech Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Strategies and some other KPI's)
Table 10-8: Bharat Biotech Product Portfolio
Table 10-9: Bharat Biotech Pipeline Products
Table 10-10: GSK Pharmaceuticals Ltd. Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Strategies and some other KPI's)
Table 10-11: GSK Pharmaceuticals Product Portfolio
Table 10-12: GSK Pharmaceuticals Pipeline Products
Table 10-13: Biological E Limited Company Profile (Company Overview, Total Revenues, EBITDA, Number of Employees, Product Portfolio, R&D, Manufacturing Sites, Strategies and some other KPI's)
Table 10-14: Biological E Limited Product Portfolio
Table 10-15: Biological E Limited Pipeline Products
Table 11-1: Pipeline Analysis of India Pediatrics Vaccine Market on the Basis of Vaccines under Clinical Trials Phase 3 (December, 2016), Sponsor, Indication, Expected Launch Year and Expected Sales in the Year of Launch in INR Million
Table 11-2: Pipeline Analysis of Global Pediatrics Vaccine Market on the Basis of Vaccines under Clinical Trials Phase 3 (December, 2016), Sponsor, Indication, Route of Administration, Estimated Study Completion Date and Location of the Study
Table 11-3: Pipeline Analysis of Global Pediatrics Vaccine Market on the Basis of Vaccines under Clinical Trials Phase 2 (December, 2016), Sponsor, Indication, Route of Administration, Estimated Study Completion Date and Location of the Study
Table 11-4: Pipeline Analysis of Global Pediatrics Vaccine Market on the Basis of Vaccines under Clinical Trials Phase 1 (December, 2016), Sponsor, Indication, Route of Administration, Estimated Study Completion Date and Location of the Study
Table 11-5: Pipeline Analysis of Global Pediatrics Vaccine Market on the Basis of Vaccines under Clinical Trials Phase 1/2 (December, 2016), Sponsor, Indication, Route of Administration, Estimated Study Completion Date and Location of the Study
Table 12-1: List of Vaccines under Development through BIRAC Support
Table 13-1: Policies Adopted by the Government to Support Industry Growth
Table 14-1: Porter's Five Forces Analysis for India Pediatric Drugs and Vaccines Market
Table 15-1: Issues and Challenges in India Pediatrics Drug and Vaccine Market
Table 16-1: Analyst Recommendations in India Pediatric Drugs and Vaccines Market
Table 16-2: GSK Technology Transfer Agreement with Fiocruz
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.